4//SEC Filing
Miser James 4
Accession 0001493152-22-033194
CIK 0001335105other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 7:18 PM ET
Size
6.7 KB
Accession
0001493152-22-033194
Insider Transaction Report
Form 4
Miser James
Chief Medical Officer
Transactions
- Award
Stock Options
2022-11-06+200,000→ 200,000 totalExercise: $2.00From: 2022-11-06Exp: 2027-11-06→ Common (200,000 underlying)
Holdings
- 83,334
Stock Options
Exercise: $7.14From: 2020-08-01Exp: 2025-08-01→ Common (83,334 underlying)
Footnotes (1)
- [F1]On November 6, 2022, the reporting person was granted options to purchase 200,000 shares of the issuer's common stock, exercisable for a period of 5 years at $2.00 per share, vesting 25% on the issuance date, and 25% on each anniversary date thereafter until fully vested, subject to continued service.
Documents
Issuer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK 0001335105
Entity typeother
Related Parties
1- filerCIK 0001857596
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 7:18 PM ET
- Size
- 6.7 KB